Subject: 616.992 - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Subject 616.992

1. 'Genotype/immunotype' correlations in resected NSCLC. (14th November 2016)

Authors:: Paik, P. K.; Hellmann, M. D.
Journal:: Annals of oncology
Issue:: Volume 28:Number 1(2017)
Page Start:: 7
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 'Oncokompas', a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors. (3rd July 2018)

Authors:: Melissant, Heleen C.; Verdonck-de Leeuw, Irma M.; Lissenberg-Witte, Birgit I.; Konings, Inge R.; Cuijpers, Pim; Van Uden-Kraan, Cornelia F.
Journal:: Acta oncologica
Issue:: Volume 57:Number 7(2018)
Page Start:: 924
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 'Optimism bias' in contemporary national clinical trial network phase III trials: are we improving?. (23rd August 2018)

Authors:: Zakeri, Kaveh; Noticewala, Sonal; Vitzthum, Lucas; Sojourner, E; Shen, Hanjie; Mell, Loren
Journal:: Annals of oncology
Issue:: Volume 29:Number 10(2018)
Page Start:: 2135
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 'Why us?' Causal attributions of childhood cancer survivors, survivors' parents and community comparisons - a mixed methods analysis. (1st February 2019)

Authors:: Vetsch, J.; Wakefield, C. E.; Doolan, E. L.; Signorelli, C.; McGill, B. M.; Moore, L.; Techakesari, P.; Pieters, R.; Patenaude, A. F.; McCarthy, M.; Cohn, R. J.
Journal:: Acta oncologica
Issue:: Volume 58:Number 2(2019)
Page Start:: 209
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. (ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis. (3rd July 2018)

Authors:: Lee, K. A.; Dunne, M.; Small, C.; Kelly, P. J.; McArdle, O.; O'Sullivan, J.; Hacking, D.; Pomeroy, M.; Armstrong, J.; Moriarty, M.; Clayton-Lea, A.; Parker, I.; Collins, C. D.; Thirion, P.
Journal:: Acta oncologica
Issue:: Volume 57:Number 7(2018)
Page Start:: 965
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. 1000TiPOPINION: A single-arm, open-label, phase IIIb study of olaparib maintenance monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) and without germline BRCA mutations (non-gBRCAm). (23rd October 2018)

Authors:: Poveda, A M; Davidson, R; Blakeley, C; Milner, A
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. 1001TiPA phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer. (23rd October 2018)

Authors:: Wahner Hendrickson, A E; Costello, B; Jewell, A; Kennedy, V; Fleming, G; Corr, B; Taylor, S E; Lea, J; Reid, J; Swisher, E; Satele, D; Allred, J; Lensing, J; Ivy, S P; Erlichman, C; Adjei, A A; Kaufmann, S
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. 1002TiPBAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer. (23rd October 2018)

Authors:: Colombo, N; Nicoletto, O; Benedetti Panici, P; Tognon, G; Lissoni, A A; Bologna, A; Tomao, F; Fossati, R; Tettamanzi, F; Rulli, E; Galli, F; Alvisi, M F; Torri, V; Biagioli, E
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. 1003TiPNeoadjuvant chemotherapy and radical surgery versus chemorradiation for stage IB2, IIA2 e IIB cervical cancer: A randomized controlled trial. (23rd October 2018)

Authors:: Reis Filho, P T F; Andrade, J M; Batista, M P; Sousa, C B; Oliveira, T H G F; Arruda, G V; Oliveira, T M G; Gabrielli, F; Genta, M L N D; Poveda, A M; Estevez Diz, M D P; Candido Dos Reis, F J
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. 1004OFinal overall survival results of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) vs R-CHOP in transplantation-ineligible patients (pts) with newly diagnosed mantle-cell lymphoma (MCL): A randomized, open-label, phase III (LYM-3002) study. (23rd October 2018)

Authors:: Cavalli, F; Jin, J; Pylypenko, H; Verhoef, G; Siritanaratkul, N; Drach, J; Raderer, M; Mayer, J; Pereira, J; Tumyan, G; Okamoto, R; Nakahara, S; Hu, P; Appiani, C; Nemat, S; Robak, T
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗